{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T06:28:45Z","timestamp":1776320925001,"version":"3.50.1"},"reference-count":8,"publisher":"Galenos Yayinevi","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["turkjsurg"],"DOI":"10.47717\/turkjsurg.2022.5489","type":"journal-article","created":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T07:26:15Z","timestamp":1740641175000},"page":"105-107","source":"Crossref","is-referenced-by-count":2,"title":["Everolimus induced pneumonitis in a liver transplant patient: Dilemma in the discrimination of pneumonia"],"prefix":"10.47717","volume":"41","author":[{"given":"Kutay","family":"Sa\u011flam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adem","family":"K\u00f6se","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murat","family":"Yal\u00e7\u0131nsoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya\u015far","family":"Bay\u0131nd\u0131r","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sezai","family":"Y\u0131lmaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2811","published-online":{"date-parts":[[2025,2,27]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"1. Arunachalam A, Ali SR, Wakefield BJ, Lane CR, Mehta AC. Everolimus induced pneumonitis in a lung transplant recipient. Oxf Med Case Reports. 2018 24;2018:omy008.","DOI":"10.1093\/omcr\/omy008"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.trre.2014.03.002","article-title":"Strategies for the management of adverse events associated with mTOR inhibitors","volume":"28","author":"Kaplan","year":"2014","unstructured":"2. Kaplan B, Qazi Y, Wellen JR. Strategies for the management of adverse events associated with mTOR inhibitors. Transplant Rev (Orlando). 2014;28:126-133.","journal-title":"Transplant Rev (Orlando)"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1111\/j.1432-2277.2009.00900.x","article-title":"Everolimus-induced pneumonitis: report of the first case in a liver transplant recipient and review of treatment options","volume":"23","author":"Schrader","year":"2010","unstructured":"3. Schrader J, Sterneck M, Klose H, Lohse AW, Nashan B, Fischer L. Everolimus-induced pneumonitis: report of the first case in a liver transplant recipient and review of treatment options. Transpl Int. 2010;23:110-113.","journal-title":"Transpl Int"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"305931","DOI":"10.1155\/2014\/305931","article-title":"Interstitial lung disease associated with mTOR inhibitors in solid organ transplant recipients: Results from a large phase III clinical trial program of everolimus and review of the literature","volume":"2014","author":"Lopez","year":"2014","unstructured":"4. Lopez P, Kohler S, Dimri S. Interstitial lung disease associated with mTOR inhibitors in solid organ transplant recipients: Results from a large phase III clinical trial program of everolimus and review of the literature. J Transplant. 2014;2014:305931.","journal-title":"J Transplant"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.transproceed.2017.12.003","article-title":"Life-threatening everolimus-associated pneumonitis: A case report and a review of the literature","volume":"50","author":"Almeida","year":"2018","unstructured":"5. Almeida F, Amorim S, Sarmento A, Santos L. Life-threatening everolimus-associated pneumonitis: A case report and a review of the literature. Transplant Proc. 2018;50:933-938.","journal-title":"Transplant Proc"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"6. Morelon E, Stern M, Isra\u00ebl-Biet D, Correas JM, Danel C, Mamzer-Bruneel MF, et al. Characteristics of sirolimus-associated interstitial pneumonitis in renal transplant patients. Transplantation. 2001;15;72:787-790.","DOI":"10.1097\/00007890-200109150-00008"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1016\/j.ejca.2011.02.014","article-title":"Management of adverse events associated with the use of everolimus in patients with advanced renal cell carcinoma","volume":"47","author":"Porta","year":"2011","unstructured":"7. Porta C, Osanto S, Ravaud A, Climent MA, Vaishampayan U, White DA, et al. Management of adverse events associated with the use of everolimus in patients with advanced renal cell carcinoma. Eur J Cancer. 2011;47:1287-1298.","journal-title":"Eur J Cancer"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"8. Siddiqui AS, Zimmerman JL. Everolimus associated interstitial pneumonitis in a liver transplant patient. Respir Med Case Rep. 2016;19:15-17.","DOI":"10.1016\/j.rmcr.2016.06.004"}],"container-title":["Turkish Journal of Surgery"],"original-title":[],"deposited":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T11:25:47Z","timestamp":1741260347000},"score":1,"resource":{"primary":{"URL":"https:\/\/turkjsurg.com\/articles\/doi\/turkjsurg.2022.5489"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,27]]},"references-count":8,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,2,27]]}},"URL":"https:\/\/doi.org\/10.47717\/turkjsurg.2022.5489","relation":{},"ISSN":["2564-6850","2564-7032"],"issn-type":[{"value":"2564-6850","type":"print"},{"value":"2564-7032","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,27]]}}}